Table 2 HCV patient characteristics and outcome of evaluation
N = 4 (100%) | |
|---|---|
Sex | |
Male | 2 (50%) |
Female | 2 (50%) |
Age (years) (mean ± SD) | 59 ± 21 |
Migrational background | |
Dutch / WE | 3 (75%) |
EE/EA | 1 (25%) |
ALT (U/l) (mean + SD) | 35 ± 18 |
Normal (0-34 U/l) | 3 (75%) |
> 1xULN | 1 (25%) |
Viral load (IU/mL) (median) | 137,605 |
Fibrosis stage | |
F0-F1 | 3 (75%) |
F2-F3 | 1 (25%) |
Management advice | |
No therapy | 1 (25%) |
Antiviral therapy | 3 (75%) |